@article{f4a7802bc10646d4ae138763ddd471fe,
title = "Angiotensin Receptor-Neprilysin Inhibition for Doxorubicin-Mediated Cardiotoxicity: Time for a Paradigm Shift",
keywords = "anthracycline, cardio-oncology, echocardiography, fibrosis, heart failure, matrix metalloproteinase, molecular imaging, neprilysin preclinical study, treatment",
author = "Hahn, {Virginia S.} and Kavita Sharma",
note = "Funding Information: Dr. Hahn has reported that she has no relationships relevant to the contents of this paper to disclose. Dr. Sharma has served as a consultant for, served on the advisory board for, and received honoraria from Novartis, Janssen, Bayer, and Bristol Myers Squibb; and has received grant support from the American Heart Association and a Johns Hopkins University Clinician Scientist Award.",
year = "2020",
month = dec,
doi = "10.1016/j.jaccao.2020.10.006",
language = "English (US)",
volume = "2",
pages = "788--790",
journal = "JACC: CardioOncology",
issn = "2666-0873",
publisher = "Elsevier Inc.",
number = "5",
}